Antonio Mendoza1, Fernando L Santoyo1, Alberto Agulló2, José L Fenández-Cañamaque3, Carmen Vivó4. 1. H. Arrixaca. Ctra Madrid-Cartagena, s/n El Palmar 30120, Murcia, Spain. 2. H. Miguel Servet. Paseo Isabel la Catolica, 1-3 Zaragoza 50009, Spain. 3. H. de Getafe. Carretera de Toledo, km 12,500 Getafe 28905, Madrid, Spain. 4. H. La Fe. Avenida Fernando Abril Martorell, 106 València 46026, Valencia, Spain.
Abstract
OBJECTIVE: To describe the management of pain prevention associated with burn care. METHODS: Multi-centre, observational, cross-sectional, descriptive study performed in 4 burn units in Spain. RESULTS: A total of 55 patients undergoing 64 procedures were analysed. Burns were classified as severe (90.4%), third-degree (78.2%) and caused by thermal agents (81.8%). Background analgesia consisted of non-opioid drugs (87.5%) and opioids (54.7%) [morphine (20.3%), morphine and fentanyl (14.1%) or fentanyl monotherapy (15.6%)]. Burn care was performed by experienced nurses (96.9%); 36.5% followed guidelines. The mean duration of procedures was 44 minutes (Statistical Deviation, SD: 20.2) and the mean duration of pain was 27 minutes (SD: 44.6). Procedural pain was primarily managed with opioid analgesics: fentanyl monotherapy and in combination (84%) and fentanyl monotherapy (48%) administered sublingually (89.1%). Patients described pain as different to usual baseline pain (97%), with a mean maximum intensity score of 4.2 points (SD: 3.3) on the VAS scale and a 34% increase in the intensity of pain. The mean patient and healthcare professional satisfaction score per procedure was 6/10 (SD: 1.9) and 5.5/10 (SD: 1.7), respectively. CONCLUSION: The results of the study describe the management of pain associated with burn care in clinical practice, helping optimise pain control.
OBJECTIVE: To describe the management of pain prevention associated with burn care. METHODS: Multi-centre, observational, cross-sectional, descriptive study performed in 4 burn units in Spain. RESULTS: A total of 55 patients undergoing 64 procedures were analysed. Burns were classified as severe (90.4%), third-degree (78.2%) and caused by thermal agents (81.8%). Background analgesia consisted of non-opioid drugs (87.5%) and opioids (54.7%) [morphine (20.3%), morphine and fentanyl (14.1%) or fentanyl monotherapy (15.6%)]. Burn care was performed by experienced nurses (96.9%); 36.5% followed guidelines. The mean duration of procedures was 44 minutes (Statistical Deviation, SD: 20.2) and the mean duration of pain was 27 minutes (SD: 44.6). Procedural pain was primarily managed with opioid analgesics: fentanyl monotherapy and in combination (84%) and fentanyl monotherapy (48%) administered sublingually (89.1%). Patients described pain as different to usual baseline pain (97%), with a mean maximum intensity score of 4.2 points (SD: 3.3) on the VAS scale and a 34% increase in the intensity of pain. The mean patient and healthcare professional satisfaction score per procedure was 6/10 (SD: 1.9) and 5.5/10 (SD: 1.7), respectively. CONCLUSION: The results of the study describe the management of pain associated with burn care in clinical practice, helping optimise pain control.
Authors: Gretchen J Summer; Kathleen A Puntillo; Christine Miaskowski; Paul G Green; Jon D Levine Journal: J Pain Date: 2007-04-16 Impact factor: 5.820
Authors: Gretchen J Carrougher; J T Ptacek; Sam R Sharar; Shelley Wiechman; Shari Honari; David R Patterson; David M Heimbach Journal: J Burn Care Rehabil Date: 2003 Jan-Feb
Authors: Matthew C Mauck; Chloe E Barton; Andrew S Tungate; Jeffrey W Shupp; Rachel Karlnoski; David J Smith; Felicia N Williams; Samuel W Jones; Christopher Sefton; Kyle McGrath; Bruce A Cairns; Samuel A McLean Journal: J Burn Care Res Date: 2022-01-05 Impact factor: 1.845